GlassScriptPhysician profile
Elise M May
NPI 1740499953
$4,635.33
in general payments reported to CMS, 2019-2025
10 companies · $1,081 in 2025
The $1,081 reported for 2025 was more than what 75% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $226 · 2021: $664 · 2022: $792 · 2023: $845 · 2024: $820 · 2025: $1,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,745.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,256.35 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $1,258.63 | 2019-2022 | |
| Mentor Worldwide LLC | $286.69 | 2019-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer, Mentor Memoryshape Breast Implant |
| Smith+Nephew, INC. | $232.94 | 2020-2021 | |
| Revance Therapeutics, INC. | $150.48 | 2025 | Daxxify |
| Ethicon US, LLC | $136.96 | 2022-2025 | Dermabond Prineo, Megadyne |
| Sientra, INC. | $118.06 | 2021-2022 | |
| Davol INC. | $107.32 | 2022 | |
| Stryker Corporation | $71.14 | 2019 | |
| Acell, INC. | $16.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elise May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.